Cargando…
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
Autor principal: | Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194770/ https://www.ncbi.nlm.nih.gov/pubmed/35699847 http://dx.doi.org/10.1007/s40744-022-00456-7 |
Ejemplares similares
-
A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
por: Drosos, Alexandros A., et al.
Publicado: (2022) -
Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119–20
por: Finsterer, Josef, et al.
Publicado: (2022) -
Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
por: Finsterer, Josef
Publicado: (2023) -
Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
por: Drosos, Alexandros A., et al.
Publicado: (2022) -
Letter to the Editor: Before Blaming SARS-CoV-2 Infection or Vaccination for Takotsubo, Differentials Should be Ruled out
por: Finsterer, Josef, et al.
Publicado: (2022)